A team from Kumamoto University has uncovered a new mechanism that could revolutionize infertility care by promoting embryo implantation. The discovery focuses on prostaglandin (PG) receptors in the ...

Prostaglandin E 2 (PGE 2), a bioactive lipid derived from arachidonic acid, mediates a broad range of physiological processes through four G protein-coupled receptor (GPCR) subtypes: EP1–EP4. While ...

Recent advancements in understanding the molecular basis of the prostaglandin D2 receptor (DP2) have significant implications for developing new anti-inflammatory and anti-allergic therapeutics. DP2, ...

Tumors actively prevent the formation of immune responses by so-called cytotoxic T cells, which are essential in combating cancer. Researchers at the Technical University of Munich (TUM) and the ...

Emory University has divulged new prostaglandin EP2 receptor (PTGER2) antagonists potentially useful for the treatment of cancer, neuropathic pain, hypertension, inflammatory bowel disease, ...

Nonsteroidal anti-inflammatory drugs increase the severity of human inflammatory bowel disease (IBD), but little is known about the mechanisms by which prostanoid inhibition modulates IBD. In April 1 ...

Prostaglandins are a family of lipid mediators derived from arachidonic acid that exert both pro-inflammatory and anti-inflammatory actions within the airway. Synthesis is initiated by cyclooxygenase ...

Prostaglandin E₂ (PGE₂) serves as a central lipid mediator in the dynamic balance between bone formation and resorption. Synthesised predominantly by cyclooxygenase-2 (COX-2) and microsomal ...

A research team from Kumamoto University has uncovered a new mechanism that could revolutionize infertility care by promoting embryo implantation. The discovery focuses on prostaglandin (PG) receptors ...

A team from Kumamoto University has uncovered a new mechanism that could revolutionize infertility care by promoting embryo implantation. The discovery focuses on prostaglandin (PG) receptors in the ...